HB Wealth Management’s SAB Biotherapeutics SABS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-263,200	Closed	-$358K	–	1252
2025 Q1	$358K	Buy	263,200 +25,800	+11%	+$35.1K	﹤0.01%	874
2024 Q4	$982K	Buy	237,400 +128,800	+119%	+$533K	0.01%	413
2024 Q3	$293K	Buy	+108,600	New	+$293K	﹤0.01%	762